BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11591771)

  • 1. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD; Sullivan JL; Bak KR; Luzuriaga K
    J Immunol; 2001 Oct; 167(8):4450-7. PubMed ID: 11591771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
    Catalina MD; Sullivan JL; Brody RM; Luzuriaga K
    J Immunol; 2002 Apr; 168(8):4184-91. PubMed ID: 11937579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.
    Hislop AD; Annels NE; Gudgeon NH; Leese AM; Rickinson AB
    J Exp Med; 2002 Apr; 195(7):893-905. PubMed ID: 11927633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G; Pepperl S; Deml L; Modrow S; Wolf H; Jilg W
    Virology; 1999 Nov; 264(2):289-97. PubMed ID: 10562493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
    Tan LC; Gudgeon N; Annels NE; Hansasuta P; O'Callaghan CA; Rowland-Jones S; McMichael AJ; Rickinson AB; Callan MF
    J Immunol; 1999 Feb; 162(3):1827-35. PubMed ID: 9973448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
    Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
    Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Fogg MH; Wirth LJ; Posner M; Wang F
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
    Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
    Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
    J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
    Vogl BA; Fagin U; Nerbas L; Schlenke P; Lamprecht P; Jabs WJ
    J Med Virol; 2012 Jan; 84(1):119-31. PubMed ID: 22095540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
    Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
    Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.